Condition
Leg Veins
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 4 (2)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07342413Phase 4Not Yet RecruitingPrimary
Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
NCT04690803Phase 4UnknownPrimary
The Effect of Cooling on Sclerotherapy Efficacy
NCT04004728Not ApplicableCompletedPrimary
Laser Treatment Of Leg Telangiectasias
NCT00366964Not ApplicableCompletedPrimary
The Efficacy Of The Wavelight Mydon Laser for Hair Removal And Treatment of Leg Veins
Showing all 4 trials